General Methods. NMR spectra were recorded on Varian Mercury 500 MHz spectrometers (125 MHz 13 C) unless otherwise noted. All NMR spectra were recorded in CDCl 3 , CD 2 Cl 2 , CD 3 OD or d 7 -DMF and referenced to residual proteo species. Peptides were dissolved for at least 1 hr prior to recording NMR spectra in order to allow for exchangeable protons to react with deuterated solvent. Flash column chromatography of organic compounds was performed using silica gel 60 (230−400 mesh). High-resolution mass spectra (EI and FAB) were provided by the California Institute of Technology Mass Spectrometry Facility. Gel permeation chromatography (GPC) was carried out in DMF with 0.2 M LiBr on two I-series MBLMW ViscoGel columns (Viscotek) connected in series with a DAWN EOS multiangle laser light scattering (MALLS) detector and an Optilab DSP differential refractometer (both from Wyatt Technology). No calibration standards were used, and dn/dc values were obtained for each injection by assuming 100% mass elution from the columns. Thin film images were collected on an Asylum MFP-3D-BIO atomic force microscope, with accompanying IGOR Pro v.5.05 software. Pyramidal-tipped silicon nitride cantilevers (Veeco DNP-S) with nominal spring constant 0.58 N/m were used for imaging. The tip of a pair of fine forceps was drawn lightly across the surface of the thin film exposing the underlying glass substrate. The edge of the surface was imaged by AFM both dry and in water, and the thickness of the film was determined. The tip speed was 1µm/sec, and the data were collected at 0.5 Hz.
Materials.
CH 2 Cl 2 and benzene were purified by passage through solvent purification columns. 1 MeOH and Et 3 N were distilled from CaH 2 and stored under an argon atmosphere. (H 2 IMes)(pyr) 2 Cl 2 Ru=CHPh was prepared from (H 2 IMes)(PCy 3 )Cl 2 Ru=CHPh according to the literature procedure.
2 cis-5-Norbornene-exo-2,3-dicarboxylic anhydride was prepared from cis-5-norbornene-endo-2,3-dicarboxylic anhydride according to the literature procedure.
3 NHydroxy(pentaethylene glycol)-cis-5-norbornene-exo-dicarboximide (1) was synthesized according to a published procedure. 4 Linear peptides were synthesized by standard solid phase peptide chemistry on 2-chlorotrityl chloride resin following previously published procedures. 4 2-Chlorotrityl chloride resin (100−200 mesh) was purchased from Novabiochem, and all Fmoc protected amino acids were purchased from Peptides International or ChemImpex. A 0.45 M solution of HBTU/HOBt was purchased from Anaspec. Endothelial cell growth medium (serumsupplemented and serum-free) without phenol red was purchased from Cell Applications. Cell culture supplies and mammalian cell LIVE/DEAD Viability/Cytotoxicity Kits were purchased from Invitrogen. All other commercially available materials were obtained from Aldrich Chemical Company and used as received unless otherwise noted. N-(Fmoc-Lysine-CO 2 H)-cis-5-norbornene-exo-dicarboximide (Fmoc-Lys(Nor)-CO 2 H, S1). A round-bottom flask was charged with cis-5-norbornene-exo-2,3-dicarboxylic anhydride (1.2 g, 7.3 mmol) and Fmoc-Lys-OH•HCl (3.1 g, 7.6 mmol). To the solid mixture was added benzene (15 mL) and Et 3 N (1.04 mL, 7.6 mmol). The flask was fitted with a Dean-Stark trap and heated to reflux for 36 h. The mixture was then allowed to cool to room temperature and diluted with 1 M aqueous HCl (10 mL). The mixture was extracted with CH 2 Cl 2 (2 × 20 mL), dried (Na 2 SO 4 ), 
N-(tert-Butyl ethylcarbamate)-cis-5-norbornene-exo-dicarboximide (Nor-Amine, 2).
A round-bottom flask was charged with cis-5-norbornene-exo-2,3-dicarboxylic anhydride (1.50 g, 9.14 mmol) and N-Boc-ethylenediamine (1.52 g, 9.5 mmol). To this mixture was added benzene (35 mL) and Et 3 N (200 µL, 1.37 mmol). The flask was fitted with a Dean-Stark trap and heated to reflux for 12 h. The mixture was then allowed to cool to room temperature and concentrated. The reaction mixture was diluted with CH 2 Cl 2 (50 mL) and washed with 0.2 M aqueous HCl (2 × 20 mL). The organic layer was washed with saturated aqueous NaCl (20 mL), dried (Na 2 SO 4 ), filtered, and concentrated under reduced pressure. Flash chromatography (SiO 2 3% MeOH− CH 2 Cl 2 ) provided 2 (2.5 g, 89%) as a white solid .0 mmol) in DMF (6 mL) was added to the resin and agitated for 1 hr. MeOH (2 mL) was then added to the mixture to cap any unreacted 2-chlorotrityl groups and agitated for an additional 10 min. The solution was then drained from the flask and washed with DMF (5 × 10 mL). A 20% solution of piperidine in DMF (10 mL) was added to the resin and agitated for 15 min. The mixture was drained and this procedure was repeated once again. The resin was washed with DMF (5 × 10 mL) and a few beads were removed and tested for complete deprotection with the Kaiser test. Upon positive Kaiser test, a solution of HBTU/HOBt (8.9 mL of a 0.45 M solution in DMF) was added to Fmoc-Gly-CO 2 H (1.19 g, 4.0 mmol) and i Pr 2 EtN (1.4 mL, 8.0 mmol) in DMF (2 mL). The solution was added to the resin and agitated for 1 hr. The solution was drained from the flask, and the resin was washed with DMF (5 × 10 mL). A few beads were removed and tested for coupling as indicated by a negative Kaiser test. If the coupling was incomplete, the process was repeated with fresh reagents. Deprotection of the Fmoc group followed by coupling with the subsequent amino acid Fmoc-Arg(Pbf)-CO 2 H was carried out as described above. Following the final Fmoc deprotection step, the amino terminus was coupled with N-(hexanoic acid)-cis-5-norbornene-exo-dicarboximide (S2) and confirmed with a negative Kaiser test. The resin was then washed with DMF (5 × 10 mL) and subsequently washed with 10% MeOH/CH 2 Cl 2 (5 × 10 mL).
Cleavage of the side-chain protected peptide from the resin was accomplished with the addition of 10 mL of CH 2 Cl 2 /CF 3 CH 2 OH/CH 3 COOH (3:1:1) to the resin. The resin was agitated briefly under an inert atmosphere and allowed to sit for 1 hr with periodic agitation every 15 min. The solution was drained, collected, and repeated once more. The resin was rinsed with 10% MeOH/CH 2 Cl 2 (2 × 10 mL). The filtrates were combined and concentrated under reduced pressure. The mixture was azeotroped with toluene (2 × 20 mL) to assure removal of excess acetic acid, washed with Et 2 O, and filtered to provide 3 (937 mg) as a white solid that was used without further purification:
1 H NMR (500 MHz, CD 3 OD) δ 6.31 (t, 2H, J = 1. 
NH 2 -Asp(O t Bu)-DPhe-Lys(Nor)-Arg(Pbf)-Gly-CO 2 H (8).
Prepared as described for 3. The initial coupling with the 2-chlorotrityl resin (0.5 g, predicted loading of 1 -1.6 mmol/gram) was performed with Fmoc-Gly-CO 2 H followed by iterative deprotection and coupling of FmocArg(Pbf)-CO 2 H, Fmoc-Lys(Nor)-CO 2 H (S1), Fmoc-D-Phe-CO 2 H, and Fmoc-Asp(O t Bu)-CO 2 H in that respective order. A final deprotection was carried out and the resin was washed with DMF followed by 10% MeOH/CH 2 Cl 2 as described above. Cleavage of the protected peptide from the resin provided 8 (440 mg) as a white solid that was used without further purification . Prepared as described for 3. The initial coupling with the 2-chlorotrityl resin (0.5 g, predicted loading of 1 -1.6 mmol/gram) was performed with Fmoc-Asp(O t Bu)-CO 2 H followed by iterative deprotection and coupling of Fmoc-Arg(Pbf)-CO 2 H, Fmoc-Lys(Nor)-CO 2 H (S1), Fmoc-D-Phe-CO 2 H, and Fmoc-Gly-CO 2 H in that respective order. A final deprotection was carried out and the resin was washed with DMF followed by 10% MeOH/CH 2 Cl 2 as described above. Cleavage of the protected peptide from the resin provided S3 (420 mg) as a white solid that was used without further purification: 1 equiv. relative to 7) and Et 3 N (35 µL) in CH 2 Cl 2 (500 µL) and stirred overnight at room temperature. The reaction mixture was precipitated into 40 mL of Et 2 O and centrifuged. The light yellow pellet was collected and dried overnight under vacuum. The solid was then dissolved in 2 mL of a mixture of TFA/TIPS/H 2 O (95:2.5:2.5) and allowed to stir at room temperature for 4 hr. The mixture was then precipitated into 40 mL of Et 2 O and the white pellet collected and dried. The solid was taken up in 1 mL DMF and dialyzed (25,000 MWCO) against water for three days changing the water every 12 h. The aqueous solution was then lyophilized to provided a white foamy solid (55 mg, 67%). 
